Catherine Duddy Wood is the founder, CEO, and CIO of Ark Invest, an investment management firm.
ARK Invest was founded in 2014 and its investment strategies include autonomous technology and robotics, next-generation internet, genomic revolution, Fintech innovations, 3D printing, Israeli innovative technology, mobility as a service, space exploration, and the overall strategy of ARK’s disrupted innovations.
Since its inception, ARK Invest has had an average return of 34% per annum.
Below is the Cathie Wood Latest Current Portfolio in 2021. The table Includes positions that make up more than 1% of the total portfolio value. To view other positions, download the excel file at the bottom of the post.
|Stock||Value||% of total portfolio||Shares||Price per share*|
|Teladoc Health Inc||2,663,467,000||4.96%||16,016,998||166|
|Coinbase Global Inc||1,422,891,000||2.65%||5,617,415||253|
|Zoom Video Communications Inc||1,419,861,000||2.64%||3,668,607||387|
|Exact Sciences Corp||1,333,447,000||2.48%||10,726,790||124|
|Spotify Technology SA||1,320,629,000||2.46%||4,792,008||276|
|Unity Software Inc||1,297,116,000||2.41%||11,810,212||110|
|CRISPR Therapeutics AG||1,258,876,000||2.34%||7,776,119||162|
|Intellia Therapeutics Inc||1,244,188,000||2.32%||7,684,441||162|
|Zillow Group Inc||1,240,545,000||2.31%||10,150,100||122|
|10X Genomics Inc||842,033,000||1.57%||4,300,037||196|
|Beam Therapeutics Inc||831,643,000||1.55%||6,461,367||129|
|Palantir Technologies Inc||808,772,000||1.51%||30,681,798||26|
|Pacific Biosciences of Califor||716,238,000||1.33%||20,481,486||35|
|Twist Bioscience Corp||673,561,000||1.25%||5,054,864||133|
|Fate Therapeutics Inc||649,458,000||1.21%||7,483,102||87|
|Iridium Communications Inc||543,583,000||1.01%||13,592,982||40|
*Price per share is the stock price on the date of the portfolio.
Download the excel file here.